Literature DB >> 2812527

Changes in cardiac neuropeptide Y after experimental myocardial infarction in rat.

C Han1, X A Wang, R R Fiscus, J Gu, J K McDonald.   

Abstract

We have investigated the hypothesis that neuropeptide Y (NPY) is released from noradrenergic sympathetic nerves during experimentally induced myocardial infarction. A left thoracotomy was performed, the left main coronary artery ligated, and the animals sacrificed 4 or 48 h later. NPY levels in heart tissue from these rats and sham-operated controls were measured with radioimmunoassay. Levels of NPY in the right atrium were greater than other regions of the rat heart. After ligation of the left coronary artery, the concentration of NPY in the infarcted area of the left ventricle was reduced at 4 and 48 h when compared to a similar area in sham-operated rats. NPY levels in the septum were unchanged. The results suggest that during myocardial infarction, NPY is released from nerves in the infarcted region and may deleteriously affect increased collateral blood flow surrounding the infarcted tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812527     DOI: 10.1016/0304-3940(89)90344-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.

Authors:  Julia Shanks; Neil Herring
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

2.  Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.

Authors:  Florim Cuculi; Neil Herring; Alberto R De Caterina; Adrian P Banning; Bernard D Prendergast; John C Forfar; Robin P Choudhury; Keith M Channon; Rajesh K Kharbanda
Journal:  Heart       Date:  2013-02-12       Impact factor: 5.994

3.  Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.

Authors:  Neil Herring; Nidi Tapoulal; Manish Kalla; Xi Ye; Lyudmyla Borysova; Regent Lee; Erica Dall'Armellina; Christopher Stanley; Raimondo Ascione; Chieh-Ju Lu; Adrian P Banning; Robin P Choudhury; Stefan Neubauer; Kim Dora; Rajesh K Kharbanda; Keith M Channon
Journal:  Eur Heart J       Date:  2019-06-21       Impact factor: 29.983

4.  Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction.

Authors:  Wei Huang; Qianhui Zhang; Hanping Qi; Pilong Shi; Chao Song; Yongsheng Liu; Hongli Sun
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

Review 5.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

6.  The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.

Authors:  Manish Kalla; Guoliang Hao; Nidi Tapoulal; Jakub Tomek; Kun Liu; Lavinia Woodward; Erica Dall'Armellina; Adrian P Banning; Robin P Choudhury; Stefan Neubauer; Rajesh K Kharbanda; Keith M Channon; Olujimi A Ajijola; Kalyanam Shivkumar; David J Paterson; Neil Herring
Journal:  Eur Heart J       Date:  2020-06-14       Impact factor: 35.855

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.